Pfizer-Biontech Covid-19 Vaccine Reduced Efficacy Vs. South Africa Variant, Study Says

Pfizer-BioNTech COVID-19 Vaccine Reduced Efficacy vs. South Africa variant, Study Says

Dating Coach Ella

Pfizer-BioNTech COVID-19 vaccine's efficacy is reduced against the 501Y.V2 variant: Study

Pfizer-BioNTech efficacy against new COVID-19 variants: Prof. Pei-Yong Shi

Pfizer: South African variant could significantly reduce vaccine protection

CNBC Television

Pfizer vaccine protection against S. African variant reduced by two-thirds

South African Covid variant may evade the Pfizer vaccine: Israeli study

CNBC Television

Pfizer-BioNTech vaccine just as effective against viral variant, study says

WXYZ-TV Detroit | Channel 7

Pfizer's Covid-19 vaccine is effective against South African variant

CNBC Television

COVID-19 Vaccine: Pfizer Less Effective In South African Variant | AFRICAN

COVID-19: Study finds Pfizer vaccine effective against new strains

Pfizer study suggests vaccine works against virus variant

KPRC 2 Click2Houston

Pfizer shot less effective in South Africa after Omicron emerges: study

Pfizer's Covid-19 vaccine appears to stop variants found in U.K., South Africa

CNBC Television

Pfizer study says vaccine protects against variant

Associated Press

Pfizer Stops 70% Omicron Hospitalizations in South Africa Study

Bloomberg Quicktake

Pfizer plans to test COVID-19 vaccine booster targeting South African variant | ANC

South African study says 2 doses of Pfizer vaccine 70% effective against Omicron hospitalization

Pfizer vaccine protects against UK and South African Covid variants, research suggests

Evening Standard

Pfizer vaccine less effective against hospitalisation: study

The Straits Times

COVID-19: 2 doses of Pfizer vaccine protects 70% against hospitalization from Omicron, study shows